- Home
- LDI vs YDES Comparison
LDI vs YDES Comparison
Compare LDI & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | LDI | YDES |
|---|---|---|
| Founded | 2010 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 954.8M | 1.1B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | LDI | YDES |
|---|---|---|
| Price | $2.59 | $12.09 |
| Analyst Decision | Sell | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 3.9M | 107.9K |
| Earning Date | 11-06-2025 | 09-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,095,780,000.00 | $510,360.00 |
| Revenue This Year | $24.99 | N/A |
| Revenue Next Year | $18.02 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 10.74 | ★ 45.76 |
| 52 Week Low | $1.01 | $5.30 |
| 52 Week High | $5.05 | $31.00 |
Technical Indicators
Market Signals| Indicator | LDI | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 44.74 | N/A |
| Support Level | $2.59 | N/A |
| Resistance Level | $2.88 | N/A |
| Average True Range (ATR) | 0.19 | 0.00 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 9.62 | 0.00 |
Price Performance
Historical ComparisonAbout LDI loanDepot Inc.
loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.